Literature DB >> 26796924

Long-Term Effects of a Screening Intervention for Depression on Suicide Rates among Japanese Community-Dwelling Older Adults.

Hirofumi Oyama1, Tomoe Sakashita2.   

Abstract

OBJECTIVES: To explore the long-term impact of a universal screening intervention for depression on suicide rates among older community-dwelling adults, with gender as an effect modifier.
DESIGN: Controlled cohort study reporting long-term follow-up of previous research.
SETTING: Two sets of three municipalities in Japan were assigned as intervention and control regions and compared with the surrounding zone and prefecture. PARTICIPANTS: Intervention area residents aged 60 years and older (14,291) were invited to participate in a 2-year intervention (2005-2006). Four population-based dynamic cohorts of residents aged 65 years and older (1999-2010) were included as subjects, 6 years before and after the intervention started. INTERVENTION: At-risk residents within the intervention region (4,918) were invited for a two-step screening program; 2,552 participated in the program linked with care/support services for 2 years. An education program open to the public was held. MEASUREMENTS: Changes in suicide from a 6-year baseline to the 2-year intervention and a 4-year follow-up in the intervention region (11,700 adults ≥65 years) were compared with a matched control and two comparison areas using mixed-effects negative binomial regression models. Suicide rates among older adults exposed to screening were compared with those of the control region.
RESULTS: Suicide rates in the intervention region decreased by 48%, which was significantly greater than in the three comparison areas. The program's benefits lasted longer for women than men. Screening exposure may be associated with decreased suicide risk over the 4-year follow-up.
CONCLUSIONS: Universal screening may decrease suicide rates among older adults, with potential gender differences in treatment response.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Suicide; community; depression screening; intervention; older adults

Mesh:

Year:  2015        PMID: 26796924     DOI: 10.1016/j.jagp.2015.10.008

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  5 in total

Review 1.  Late-life suicide prevention strategies: current status and future directions.

Authors:  Kim Van Orden; Charlene Deming
Journal:  Curr Opin Psychol       Date:  2017-09-08

Review 2.  Suicide Prevention Interventions and Their Linkages in Multilayered Approaches for Older Adults: A Review and Comparison.

Authors:  Tomoe Sakashita; Hirofumi Oyama
Journal:  Front Public Health       Date:  2022-05-10

3.  Analysis of attempted suicide episodes presenting to the emergency department: comparison of young, middle aged and older people.

Authors:  Soo Hyun Kim; Han Joon Kim; Sang Hoon Oh; Kyungman Cha
Journal:  Int J Ment Health Syst       Date:  2020-06-22

4.  Effectiveness of a village-based intervention for depression in community-dwelling older adults: a randomised feasibility study.

Authors:  In Mok Oh; Maeng Je Cho; Bong-Jin Hahm; Byung-Soo Kim; Jee Hoon Sohn; Hye Won Suk; Bu Young Jung; Hye Jung Kim; Hyeon A Kim; Ki Bok Choi; Da Hye You; Ah Reum Lim; In Ok Park; Jeung Hyuck Ahn; Hee Lee; Yeon Hee Kim; Mi Ra Kim; Jee Eun Park
Journal:  BMC Geriatr       Date:  2020-03-04       Impact factor: 3.921

5.  Depression screening using patient-targeted feedback in general practices: study protocol of the German multicentre GET.FEEDBACK.GP randomised controlled trial.

Authors:  Sebastian Kohlmann; Marco Lehmann; Marion Eisele; Lea-Elena Braunschneider; Gabriella Marx; Antonia Zapf; Karl Wegscheider; Martin Härter; Hans-Helmut König; Jürgen Gallinat; Stefanie Joos; Gaby Resmark; Antonius Schneider; Christine Allwang; Joachim Szecsenyi; Christoph Nikendei; Sven Schulz; Katja Brenk-Franz; Martin Scherer; Bernd Löwe
Journal:  BMJ Open       Date:  2020-09-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.